Mauna Kea Technologies SA (EPA:ALMKT)

Market Cap	21.72M +166.7%
Revenue (ttm)	8.38M +2.4%
Net Income	10.63M
EPS	0.06
Shares Out	195.30M
PE Ratio	1.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	132,638
Open	0.1140
Previous Close	0.1140
Day's Range	0.1112 - 0.1140
52-Week Range	0.0692 - 0.2315
Beta	0.94
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 8, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures, and help diagnose and treat patients. The company was incorporated in ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 59
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMKT

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 19, 2026

Data Sources Report a data error